About Nuvation Bio Inc.
Nuvation Bio is a clinical-stage oncology company developing NUV-868, NUV-422, and other novel cancer drugs targeting treatment-resistant tumors.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Nuvation Bio Inc.. Response typically within 48 hours.
Company Info
TypePublic
StockNUVB (NYSE)
Founded2018
Employees200
Revenue$35M
HQNew York, USA
